tiprankstipranks
Abeona Therapeutics (ABEO)
NASDAQ:ABEO
US Market

Abeona Therapeutics (ABEO) Income Statement

Compare
1,348 Followers

Abeona Therapeutics Income Statement

Last quarter (Q3 2024), Abeona Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Abeona Therapeutics's net income was $-30.27M. See Abeona Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.50M$ 1.41M$ 3.00M$ 10.00M$ 0.00
Gross Profit
$ 1.90M$ 964.00K$ -1.46M$ -20.14M$ -8.68M
Operating Expenses
$ 49.03M$ 46.22M$ 60.37M$ 58.50M$ 77.09M
Depreciation and Amortization
$ 3.20M$ 4.58M$ 4.46M$ 5.60M$ 8.68M
EBITDA
$ -50.57M$ -34.38M$ -76.80M$ -74.52M$ -67.61M
Operating Income
$ -47.13M$ -45.26M$ -89.84M$ -81.42M$ -77.09M
Other Income/Expenses
$ -7.05M$ 11.22M$ 4.90M$ -2.81M$ 808.00K
Pretax Income
$ -54.19M$ -39.70M$ -84.94M$ -84.23M$ -76.28M
Net Income
$ -54.19M$ -31.81M$ -88.61M$ -88.35M$ -76.68M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.53$ -4.05$ -22.50$ -23.84$ -38.07
Diluted EPS
$ -2.53$ -4.05$ -22.50$ -23.84$ -38.07
Weighted Average Shares Outstanding
21.38M 7.86M 3.94M 3.71M 2.01M
Weighted Average Shares Outstanding (Diluted)
21.38M 7.86M 3.94M 3.71M 2.01M
Currency in USD

Abeona Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis